Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever
- PMID: 25932235
- PMCID: PMC4402882
Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever
Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) is known to be associated with cardiac damage. Brain type natriuretic peptide (BNP) is secreted from stressed myocardium.
Objectives: This study investigated that BNP levels in CCHF and its association with clinical course of disease.
Methods: Consecutive CCHF diagnosis confirmed patients were enrolled to the study. Results of patients were compared with age-sex-matched healthy volunteers. Blood samples for BNP levels were collected from the patients during emergency room applications. Mortality, hospitalization duration and other disease severity predictors (thrombocyte count, hemoglobin, white blood cell count, alanine aminotransferase, aspartate aminotransferase, prothrombin time, lactate dehydrogenase, international normalized ratio, activated partial thromboplastin time) were recorded. These parameters' correlations with BNP levels were analyzed.
Result: Forty-three CCHF patients and 28 control subjects recruited to the study. Groups were similar for age and gender. There was no mortality. Levels of BNP were found to be significantly higher in patients than control subjects (100.4±45.4 vs. 78.0±40.4, P=0.033). But BNP levels were not correlated with duration of hospitalization and disease severity predictors (P > 0.05).
Conclusions: This study showed that BNP levels are modestly increased in CCHF but this increase does not correlated with disease severity predictors.
Keywords: Crimean-Congo hemorrhagic fever; brain type natriuretic peptide; cardiac damage.
Similar articles
-
Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever.Biomark Med. 2023 Jun;17(11):533-540. doi: 10.2217/bmm-2023-0330. Epub 2023 Oct 4. Biomark Med. 2023. PMID: 37791843
-
Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.Arch Virol. 2018 Mar;163(3):609-616. doi: 10.1007/s00705-017-3653-1. Epub 2017 Nov 20. Arch Virol. 2018. PMID: 29159591
-
C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever.Int J Infect Dis. 2012 Aug;16(8):e616-20. doi: 10.1016/j.ijid.2012.04.009. Epub 2012 Jun 12. Int J Infect Dis. 2012. PMID: 22695238
-
Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever.Antiviral Res. 2016 Aug;132:233-43. doi: 10.1016/j.antiviral.2016.06.011. Epub 2016 Jul 1. Antiviral Res. 2016. PMID: 27378224 Review.
-
Crimean-Congo hemorrhagic fever.Antiviral Res. 2004 Dec;64(3):145-60. doi: 10.1016/j.antiviral.2004.08.001. Antiviral Res. 2004. PMID: 15550268 Review.
References
-
- Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145–60. - PubMed
-
- Akinci E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013;13:429–37. - PubMed
-
- Engin A, Yilmaz MB, Elaldi N, Erdem A, Yalta K, Tandogan I, Kaya S, Bakir M, Dokmetas I. Crimean-Congo hemorrhagic fever: does it involve the heart? Int J Infect Dis. 2009;13:369–373. - PubMed
-
- Gul I, Kaya A, Güven AS, Karapinar H, Küçükdurmaz Z, Yilmaz A, Içağasioğlu FD, Tandoğan I. Cardiac findings in children with Crimean congo hemorrhagic fever. Med Sci Monit. 2011;17:CR457–60. - PubMed
-
- Yilmaz MB, Engin A, Bektasoglu G, Zorlu A, Ege MR, Bakir M, Dokmetas I. Does electrocardiography at admission predict outcome in crimeancongo hemorrhagic fever? J Vector Borne Dis. 2011;48:150–154. - PubMed
LinkOut - more resources
Full Text Sources